CSBR
NASDAQ
Life Sciences Tools & Services
$6.10
USD
-$0.03 (-0.49%)
At close: Jul 20, 2026, 4:00 PM EDT
Market Cap:
$84.71M
Volume:
2.1K
Previous Close
$6.13
Day Range
$6.10 - $6.15
52 Week Range
$5.49 - $8.74
Average Volume (10 Days)
10.0K
P/E Ratio (TTM)
—
Dividend Yield
—
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company is headquartered in Hackensack, New Jersey and currently employs 213 full-time employees. The firm is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions (TOS). This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. The company also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.
CEO
Mr. Robert Brainin
Headquaters
Hackensack, NEW JERSEY, US
Founded
1988
Employees
213
HYFT
MindWalk Holdings Corp
$1.43
-2.0%
LFCR
Lifecore Biomedical Inc
$4.69
+0.2%